Half-year report · Q2

Period2024-12-01 → 2025-05-31
Filed2025-07-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥4.3bn2024-12-01 → 2025-05-31Cons.Net sales
Revenue¥8.9bn2023-12-01 → 2024-11-30Cons.Net sales (5-year summary)
Revenue¥4.2bn2023-12-01 → 2024-05-31Cons.Net sales
Operating income¥199m2024-12-01 → 2025-05-31Cons.Operating income
Operating income¥202m2023-12-01 → 2024-05-31Cons.Operating income
Ordinary income¥183m2024-12-01 → 2025-05-31Cons.Ordinary income
Ordinary income¥390m2023-12-01 → 2024-11-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥212m2023-12-01 → 2024-05-31Cons.Ordinary income
Profit before tax¥183m2024-12-01 → 2025-05-31Cons.Income before income taxes
Profit before tax¥252m2023-12-01 → 2024-05-31Cons.Income before income taxes
Net income (owners)¥135m2024-12-01 → 2025-05-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥336m2023-12-01 → 2024-11-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥193m2023-12-01 → 2024-05-31Cons.Profit loss attributable to owners of parent
Net income¥135m2024-12-01 → 2025-05-31Cons.Profit loss
Net income¥193m2023-12-01 → 2024-05-31Cons.Profit loss
Total assets¥8.8bnat 2025-05-31Cons.Assets
Total assets¥8.5bnat 2024-11-30Cons.Assets
Total assets¥8.0bnat 2024-05-31Cons.Total assets (5-year summary)
Total liabilities¥5.8bnat 2025-05-31Cons.Liabilities
Total liabilities¥5.6bnat 2024-11-30Cons.Liabilities
Net assets / equity¥2.9bnat 2025-05-31Cons.Net assets
Net assets / equity¥2.9bnat 2024-11-30Cons.Net assets
Net assets / equity¥2.7bnat 2024-05-31Cons.Net assets (5-year summary)
Cash and deposits¥1.3bnat 2025-05-31Cons.Cash and deposits
Cash and deposits¥745mat 2024-11-30Cons.Cash and deposits
Cash & equivalents¥1.3bnat 2025-05-31Cons.Cash and cash equivalents
Cash & equivalents¥745mat 2024-11-30Cons.Cash and cash equivalents
Cash & equivalents¥947mat 2024-05-31Cons.Cash and cash equivalents
Cash & equivalents¥1.0bnat 2023-11-30vCons.Cash and cash equivalents
Operating cash flow¥566m2024-12-01 → 2025-05-31Cons.Net cash provided by used in operating activities
Operating cash flow¥143m2023-12-01 → 2024-11-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥90m2023-12-01 → 2024-05-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥216m2024-12-01 → 2025-05-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥305m2023-12-01 → 2024-11-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥96m2023-12-01 → 2024-05-31Cons.Net cash provided by used in investment activities
Financing cash flow¥187m2024-12-01 → 2025-05-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥139m2023-12-01 → 2024-11-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥101m2023-12-01 → 2024-05-31Cons.Net cash provided by used in financing activities
EPS (basic)¥110.522024-12-01 → 2025-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥276.222023-12-01 → 2024-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥158.382023-12-01 → 2024-05-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio33.5%at 2025-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio33.8%at 2024-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio34.2%at 2024-05-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue2024-12-01 → 2025-05-31¥4.3bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue external2024-12-01 → 2025-05-31¥4.3bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentsegment profit2024-12-01 → 2025-05-31¥184m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue2024-12-01 → 2025-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue external2024-12-01 → 2025-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentsegment profit2024-12-01 → 2025-05-31¥15m
Total Of Reportable Segments And Otherssegment totalrevenue2024-12-01 → 2025-05-31¥4.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-12-01 → 2025-05-31¥4.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-12-01 → 2025-05-31¥199m
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue2023-12-01 → 2024-05-31¥4.2bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue external2023-12-01 → 2024-05-31¥4.2bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentsegment profit2023-12-01 → 2024-05-31¥187m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue2023-12-01 → 2024-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue external2023-12-01 → 2024-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentsegment profit2023-12-01 → 2024-05-31¥15m
Total Of Reportable Segments And Otherssegment totalrevenue2023-12-01 → 2024-05-31¥4.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-12-01 → 2024-05-31¥4.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-12-01 → 2024-05-31¥202m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 484
ItemContextValueUnit
Net defined benefit liabilityPrior1YearInstant109563000JPY
Net defined benefit liabilityCurrentQuarterInstant85178000JPY
Other nclPrior1YearInstant113297000JPY
Other nclCurrentQuarterInstant106892000JPY
Noncurrent liabilitiesPrior1YearInstant761943000JPY
Noncurrent liabilitiesCurrentQuarterInstant990660000JPY
LiabilitiesPrior1YearInstant5649135000JPY
LiabilitiesCurrentQuarterInstant5825703000JPY
Capital stockPrior1YearInstant610000000JPY
Capital stockCurrentQuarterInstant610000000JPY
Capital surplusPrior1YearInstant58437000JPY
Capital surplusCurrentQuarterInstant58437000JPY
Retained earningsPrior1YearInstant2156499000JPY
Retained earningsCurrentQuarterInstant2218002000JPY
Treasury stockPrior1YearInstant-8326000JPY
Treasury stockCurrentQuarterInstant-8326000JPY
Shareholders equityPrior1YearInstant2816610000JPY
Shareholders equityCurrentQuarterInstant2878114000JPY
Valuation difference on available for sale securitiesPrior1YearInstant13108000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant15517000JPY
Foreign currency translation adjustmentPrior1YearInstant52677000JPY
Foreign currency translation adjustmentCurrentQuarterInstant44691000JPY
Valuation and translation adjustmentsPrior1YearInstant65786000JPY
Valuation and translation adjustmentsCurrentQuarterInstant60209000JPY
Net assetsPrior1YearInstant2882396000JPY
Net assetsCurrentQuarterInstant2938323000JPY
Liabilities and net assetsPrior1YearInstant8531532000JPY
Liabilities and net assetsCurrentQuarterInstant8764026000JPY
Net salesPrior1YTDDuration4248278000JPY
Net salesCurrentYTDDuration4314059000JPY
Cost of salesPrior1YTDDuration3470153000JPY
Cost of salesCurrentYTDDuration3512767000JPY
Gross profitPrior1YTDDuration778125000JPY
Gross profitCurrentYTDDuration801292000JPY
Selling general and administrative expensesPrior1YTDDuration575706000JPY
Selling general and administrative expensesCurrentYTDDuration602343000JPY
Operating incomePrior1YTDDuration202418000JPY
Operating incomeCurrentYTDDuration198948000JPY
Interest income noiPrior1YTDDuration1521000JPY
Interest income noiCurrentYTDDuration1822000JPY
Dividends income noiPrior1YTDDuration1095000JPY
Dividends income noiCurrentYTDDuration1134000JPY
Reversal of allowance for doubtful accounts noiPrior1YTDDuration637000JPY
Reversal of allowance for doubtful accounts noiCurrentYTDDuration631000JPY
Foreign exchange gains noiPrior1YTDDuration3222000JPY
Foreign exchange gains noiCurrentYTDDuration-JPY
Income from contribution to facilities noiPrior1YTDDuration10000000JPY
Income from contribution to facilities noiCurrentYTDDuration-JPY
Other noiPrior1YTDDuration2798000JPY
Other noiCurrentYTDDuration4302000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-11-30pass rounding
balance sheet identityconsolidated 2025-05-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-11-30pass
statement vs summary · net assetsconsolidated 2025-05-31pass
statement vs summary · net income attributable to parentconsolidated 2023-12-01/2024-05-31pass
statement vs summary · net income attributable to parentconsolidated 2024-12-01/2025-05-31pass
statement vs summary · operating cash flowconsolidated 2023-12-01/2024-05-31pass
statement vs summary · operating cash flowconsolidated 2024-12-01/2025-05-31pass
statement vs summary · revenueconsolidated 2023-12-01/2024-05-31pass
statement vs summary · revenueconsolidated 2024-12-01/2025-05-31pass
statement vs summary · total assetsconsolidated 2024-11-30pass
statement vs summary · total assetsconsolidated 2025-05-31pass